Policymakers often raise the question “Do ‘new’ and innovative drugs costs too much?”. Although innovative ‘new’ drugs may be more expensive than alternative, existing, drug therapies, they are extensively reviewed for their benefits and costs and are considered to be among the most cost effective treatments available. Furthermore, ‘new’ drugs are also expected to reduce mortality in diseases that claim many lives today, such as cancer.
So, are ‘new’ and innovative…
Added by Peter Hofland, PhD on September 12, 2004 at 8:00pm — No Comments
2013
2012
2011
2010
2009
2008
2007
2005
2004
2001
© 2013 Created by Peter Hofland, PhD.
